The OLS has just launched the Biomanufacturing Fund (BMF) to support life science companies investing in manufacturing projects in the UK. The BMF will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of 30th June and 31st July. If you think you could benefit from this fund please contact the BMF team at bmf@officeforlifesciences.gov.uk You can find out more details about the fund at this webpage
Read our other news
NCC has chosen Cheshire as the initial location of its open-access Carbon Fibre Development Facility, which aims to support the UK's strategic growth sectors
Family-run haulier S. Cooper & Sons has marked its 100-year milestone with a celebration to remember for its staff and partners
A lawn care business based in Chester and Northwich is celebrating 20 years since establishing its franchise